Organs-on-chips enter the laboratories of big pharma
Interviewee/Contributor
Lorna Ewart and Geraldine Hamilton
Organisation
AstraZeneca Plc and Emulate Inc
Research Directory
Combination therapy in oncology
Interviewee/ContributorGerben Moolhuizen and Kees MeliefOrganisationISA Pharmaceuticals BVASCO 2018: Oncology trials break new ground
Interviewee/ContributorBruno PagliaraThe myth of biotech self-determination
Interviewee/ContributorEdwin MosesOrganisationAblynx NVPharma slow to adopt SE incorporation
Interviewee/ContributorWilliam EllingtonOrganisationMedNousHow surrogate markers impact drug development
Interviewee/ContributorShiva MemariOrganisationVertical KnowingCurbing the use of unproven cellular therapies
Interviewee/ContributorMassimo DominiciOrganisationInternational Society Cell and Gene TherapyOwnership lessons for European biotechs
Interviewee/ContributorJohn RountreeOrganisationNovasectaSourcing antibiotics from the nematode worm
Interviewee/ContributorPhilippe Villain-GuillotOrganisationNosopharm SASInnovation spreads across the oncology sector
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma Consulting